Announcement Details
View all announcements
View all announcements
Change of Registered Office
01 Jul 2022
Hemogenyx Pharmaceuticals plc
(“Hemogenyx Pharmaceuticals” or the “Company”)
Change of Registered Office
Hemogenyx Pharmaceuticals plc announces that its registered office address has changed with immediate effect to 6th Floor, 60 Gracechurch Street, London, EC3V 0HR, United Kingdom.
Enquiries:
Hemogenyx Pharmaceuticals plc | https://hemogenyx.com |
Dr Vladislav Sandler, Chief Executive Officer & Co-Founder | headquarters@hemogenyx.com |
Peter Redmond, Director | peter.redmond@hemogenyx.com |
SP Angel Corporate Finance LLP | Tel: +44 (0)20 3470 0470 |
Matthew Johnson, Vadim Alexandre, Adam Cowl | |
Peterhouse Capital Limited | Tel: +44 (0)20 7469 0930 |
Lucy Williams, Duncan Vasey, Charles Goodfellow |
A new era for the treatment of blood diseases
Our aim is to change the way in which bone marrow/hematopoietic stem cell transplants are performed and improve their efficacy.